Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3773-3778

  Wongpaiboonwattana, Wikrom ^a   Tosukhowong, Piyaratana ^a   Dissayabutra, Thasinas ^a   Mutirangura, Apiwat ^a   Boonla, Chanchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Bladder cancer; DNA methylation; LINE 1; Oxidative stress; RUNX3

Indexed keywords

EID: 84882656834     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3773     Document Type: Article

References (30)

1. Akcay T, Saygili I, Andican G, Yalcin V (2003). Increased formation of 8-hydroxy-2'-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol Int, 71, 271-4.
2. Cedar H, Bergman Y (2012). Programming of DNA methylation patterns. Annu Rev Biochem, 81, 97-117.
3. Chalitchagorn K, Shuangshoti S, Hourpai N, et al (2004). Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene, 23, 8841-6.
4. Chia N, Wang L, Lu X, et al (2011). Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics, 6, 853-6.
5. Ehrlich M, Lacey M (2013). DNA hypomethylation and hemimethylation in cancer. Adv Exp Med Biol, 754, 31-56.
6. Gasche JA, Hoffmann J, Boland CR, Goel A (2011). Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer, 129, 1053-63.
7. Halliwell B, Long LH, Yee TP, Lim S, Kelly R (2004). Establishing biomarkers of oxidative stress: the measurement of hydrogen peroxide in human urine. Curr Med Chem, 11, 1085-92.
8. Hitchler MJ, Domann FE (2007). An epigenetic perspective on the free radical theory of development. Free Radic Biol Med, 43, 1023-36.
9. Homma N, Tamura G, Honda T, et al (2006). Spreading of methylation within RUNX3 CpG island in gastric cancer. Cancer Sci, 97, 51-6.
10. Jeong P, Min BD, Ha YS, et al (2012). RUNX3 methylation in normal surrounding urothelium of patients with non-muscleinvasive bladder cancer: potential role in the prediction of tumor progression. Eur J Surg Oncol, 38, 1095-100.
11. Jurgens B, Schmitz-Drager BJ, Schulz WA (1996). Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res, 56, 5698-703.
12. Kang KA, Zhang R, Kim GY, Bae SC, Hyun JW (2012). Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol, 33, 403-12.
13. Kazazian HH Jr, Goodier JL (2002). LINE drive retrotransposition and genome instability. Cell, 110, 277-80.
14. Kim EJ, Kim YJ, Jeong P, et al (2008). Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor. J Urol, 180, 1141-5.
15. Kim TY, Lee HJ, Hwang KS, et al (2004). Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest, 84, 479-84.
16. Kim WJ, Kim EJ, Jeong P, et al (2005). RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res, 65, 9347-54.
17. Kim WJ, Lee JW, Quan C, et al (2011). Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300. J Urol, 185, 2366-75.
18. Lau QC, Raja E, Salto-Tellez M, et al (2006). RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res, 66, 6512-20.
19. Lertratanangkoon K, Orkiszewski RS, Scimeca JM (1996). Methyl-donor deficiency due to chemically induced glutathione depletion. Cancer Res, 56, 995-1005.
20. Li QL, Kim HR, Kim WJ, et al (2004). Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun, 314, 223-8.
21. O'Hagan HM, Wang W, Sen S, et al (2011). Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell, 20, 606-19.
22. Opanuraks J, Boonla C, Saelim C, et al (2010). Elevated urinary total sialic acid and increased oxidative stress in patients with bladder cancer. Asian Biomed, 4, 703-10.
23. Patchsung M, Boonla C, Amnattrakul P, et al (2012). Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential. PLoS One, 7, 37009.
24. Ploeg M, Aben KK, Kiemeney LA (2009). The present and future burden of urinary bladder cancer in the world. World J Urol, 27, 289-93.
25. Sanchez-Carbayo M (2012). Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biol, 33, 347-61.
26. Wachsman JT (1997). DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res, 375, 1-8.
27. Weitzman SA, Turk PW, Milkowski DH, Kozlowski K (1994). Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci USA, 91, 1261-4.
28. Wilhelm CS, Kelsey KT, Butler R, et al (2010). Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res, 16, 1682-9.
29. Wolff EM, Liang G, Cortez CC, et al (2008). RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res, 68, 6208-14.
30. Yan C, Kim YW, Ha YS, et al (2012). RUNX3 methylation as a predictor for disease progression in patients with nonmuscle- invasive bladder cancer. J Surg Oncol, 105, 425-30.